Objective To study the clinical rescue for basicranial fracture complicated with massive hemorrhage.Methods The therapies for 20 patients of basicranial fracture complicated with massive hemorrhage treated in our hospital within 3 years were analyzed retrospectively.Results Among 20 patients,16 cases were male,4 cases were female.7 cases were simple anterior basicranial fracture with massive hemorrhage,1 case was the delayed massive hemorrhage in cavernous fistula caused by anterior basicranial fracture,12 cases were anterior and mid basicranial fracture complicated with massive hemorrhage.In consequence,6 cases were secondary cerebrospinal leak,8 cases recovered,8 cases died.Conclusion The basicranial fracture complicated with massive hemorrhage is a very dangerous symptom with high death rate and high disability rate.The patients should be rescued actively.

ObjectiveTo analyze the development mechanism and investigate the more effective therapeutic method of the multiple system organs failure (MSOF) after severe craniocerebral injury.MethodsThe clinical data of 21 MSOF cases after severe craniocerebral injury was analyzed retrospectively.ResultsOf all 21 cases, 2 cured, 7 mended and 12 died with death rate 57% and deformity rate 33.3%.ConclusionTo severe craniocerebral injury, comprehensive, timely and effective therapeutic method is the key to reduce the occurrence of MSOF and the rate of death and deformity.

Objective　To investigate the relationship between histological classification of lung cancer and protein tyrosine phosphatase. Methods　The expression of protein tyrosine phosphatase in bronchial epithelia from 34 patients with benign pulmonary lesions and 121 patients with primary pulmonary carcinoma was examined by immunohistochemical staining method. Results　The positive rate of protein tyrosine phosphatase expression was 95.03％±2.10％ in 34 patients with benign pulmonary lesions, 43.59％±14.41％ in 121 patients with primary pulmonary carcinoma; 47.57％±16.26％ in 46 patients with adenocarcinoma, 40.59％±14.04％ in 48 patients with squamous cell carcinoma, 42.13％±9.84％ in 27 patients with adenosquamous carcinoma; 31.63％±10.34％ in 21 patients with poor differentiated squamous cell carcinoma, 41.39％±9.35％ in 18 patients with intermediate differentiated squamous cell carcinoma, 59.90％±8.61％ in 9 patients with well differentiated squamous cell carcinoma; 34.14％±12.53％ in 16 patients with poor differentiated adenocarcinoma, 52.10％±12.19％ in 26 patients with intermediate differentiated adenocarcinoma, and 63.05％±15.84％ in 4 patients with well differentiated adenocarcinoma. A significant difference of protein tyrosine phosphatase positive expression was observed between benign pulmonary lesions and primary pulmonary carcinomas, and between poor differentiated primary pulmonary carcinomas and well differentiated primary pulmonary carcinomas (P＜0.01 or P＜0.05). Conclusion　Detection of protein tyrosine phosphatase may be helpful to differentiate pulmonary lesions from lung cancer and be regarded as one of the indices in predicting the prognosis of patients with primary pulmonary carcinomas.